Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01276977 · ClinicalTrials.gov registry record · NA
Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine
A NA study of Migraine Headache and Headache Disorders, sponsored by California Medical Clinic for Headache.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT01276977: Completed NA study of Migraine Headache and Headache Disorders, sponsored by California Medical Clinic for Headache.
NCT01276977 is a NA study of Migraine Headache and Headache Disorders that has completed, run by California Medical Clinic for Headache. The registered enrollment target is 80 participants, below the 146-participant average among 6 other Migraine Headache trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01276977, a NA study of Migraine Headache and Headache Disorders, has completed, sponsored by California Medical Clinic for Headache.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to Compare the efficacy of zolmitriptan 5 mg nasal spray vs. eletriptan 40 mg tablet in the acute treatment of migraine. To develop and evaluate a set of importance weights for a predefined set of treatment attributes for migraine suffers using zolmitriptan 5 mg nasal spray vs. eletriptan 40 mg tablet. To contrast the efficacy of zolmitriptan 5 mg nasal spray vs. eletriptan 40 mg tablet at early time points. To analyze the patterns of self-reported tolerability of migraine sufferers using zolmitriptan 5 mg nasal spray vs. eletriptan 40 mg tablet.
Conditions Studied
Interventions
- DRUG Zolmitriptan 5 mg Nasal Spray
- DRUG Eletriptan 40 mg tablet
Study Locations (1)
California
- California Medical Clinic for Headache - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-12 |
| Phase | NA |
What the finished NCT01276977 record still lists
NCT01276977 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 146-participant average among 6 other Migraine Headache trials with a reported enrollment target (45% lower).
The record links to 3 conditions, with Migraine Headache appearing as the primary indexed condition, and to 2 interventions - of which Zolmitriptan 5 mg Nasal Spray is the first listed.
NCT01276977 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01276977 about?
NCT01276977 is a clinical study titled "Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine". The purpose of this study is to Compare the efficacy of zolmitriptan 5 mg nasal spray vs. eletriptan 40 mg tablet in the acute treatment of migraine. To develop and evaluate a set of importance weights for a predefined set of treatment attributes for migraine suffers using zolmitriptan 5 mg nasal s...
What is the current status of trial NCT01276977?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2008-04. Estimated completion is 2010-12.
What conditions does trial NCT01276977 study?
This clinical trial studies the following conditions: Migraine Headache, Headache Disorders, Acute Migraine.
What interventions are being tested in trial NCT01276977?
The interventions under investigation include: Zolmitriptan 5 mg Nasal Spray (DRUG), Eletriptan 40 mg tablet (DRUG).
Who is sponsoring clinical trial NCT01276977?
This trial is sponsored by California Medical Clinic for Headache, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01276977 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Light Exposure, Migraine Outcomes, and Sleep Quality
RECRUITING · NA
-
Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache
COMPLETED · NA
-
TelemEdiciNe-bAsed Cognitive TherapY for Migraines
COMPLETED · NA
-
Efficacy, Tolerability, and Safety of DFN-15
COMPLETED · Phase 3
-
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache
COMPLETED · Phase 2
-
Greater Occipital Nerve Block for Migraine Prophylaxis
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia